Company

GlycoEra AG

Biotechnology Research Wädenswil, Zurich, Ch 36 employees

Employees: 36
Contacts: 4
Emails: 4
Phones: 2

www.glycoera.com LinkedIn Crunchbase

GlycoEra AG Overview

Headquarters: Wädenswil, Zurich, Ch
Website: www.glycoera.com
Industry: Biotechnology Research
Employees: 36
Founded: 2020
Funding: 130.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Glycoengineering Therapeutic product development Biopharmaceutical CMC development

About GlycoEra AG

GlycoEra is positioned as the leading precision protein degradation company. Bifunctional biologics (G-LyTACs), designed by our novel and proprietary technology bind to disease-causing proteins and transport them to the lysosome using naturally occurring endocytic receptors. The disease-causing proteins are degraded in the lysosome and removed from the body. Unlike intracellular protein degraders, like PROTACs and molecular glues, our technology can access targets that are extracellular and membrane proteins, thereby opening up novel targets and therapeutic areas for intervention.

GlycoEra AG Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

GlycoEra AG Org Chart

Sample employees and titles

Name	Title	Location	Contact
Tanmoy Ganguly		Westford, Massachusetts, United States	Email
Kellie Cotter	Principal Scientist - Synthetic Biology, Molecular Biology, Protein Engineering and Platform Development	Zurich, Switzerland	Email Phone
Manuela Mally	VP Technology and Co-founder Glycoera Ag	Wädenswil, Zurich, Switzerland	Email
Rick Shea		Cohasset, Massachusetts, United States	Email Phone